Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now
Equities

Endymed Ltd

ENDYF:PNK

Endymed Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Endymed Ltd, formerly Applisonix Ltd, is an Israel-based company. The Company operated for two years under the Ma’ayan Technology Incubator Group, an investment group for high technology premature companies. The Company has three wholly-owned subsidiaries, two in Israel and one subsidiary in Hong Kong. The Company, through wholly-owned subsidiary CureLight Medical Ltd, develops, manufactures and markets ultrasound hair removal equipment based on an in-house technology for both professionals and home users. Starting from January 2012, through wholly owned subsidiary EndyMed Medical Ltd, the Company is also engaged in design, development and marketing of aesthetic treatment equipment based on radiofrequency technology, which is a solution for fractional skin resurfacing, wrinkle treatment, skin tightening, scar treatment and body contouring.

  • Revenue in ILS (TTM)74.60m
  • Net income in ILS-3.18m
  • Incorporated2004
  • Employees46.00
  • Location
    Endymed Ltd12 LESHEM, EZOR TA'ASIYA TSFONICAESAREA 3088900IsraelISR
  • Phone+972 46309100
  • Fax+972 46309101
  • Websitehttps://endymed.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.